AI-Designed Drug Shows Potential to Reverse Aging Markers in Human Study
An AI-designed drug developed by Insilico Medicine has shown potential to reduce biological aging markers in a clinical study, though researchers say more trials are needed.
September 8
by Reid Ashton




